Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species-dependent JNK and endothelial nitric oxide synthase activation and overrides imatinib resistance

Cancer Sci. 2012 Jan;103(1):88-99. doi: 10.1111/j.1349-7006.2011.02107.x. Epub 2011 Nov 7.

Abstract

Alcoholic extract of Piper betle (Piper betle L.) leaves was recently found to induce apoptosis of CML cells expressing wild type and mutated Bcr-Abl with imatinib resistance phenotype. Hydroxy-chavicol (HCH), a constituent of the alcoholic extract of Piper betle leaves, was evaluated for anti-CML activity. Here, we report that HCH and its analogues induce killing of primary cells in CML patients and leukemic cell lines expressing wild type and mutated Bcr-Abl, including the T315I mutation, with minimal toxicity to normal human peripheral blood mononuclear cells. HCH causes early but transient increase of mitochondria-derived reactive oxygen species. Reactive oxygen species-dependent persistent activation of JNK leads to an increase in endothelial nitric oxide synthase-mediated nitric oxide generation. This causes loss of mitochondrial membrane potential, release of cytochrome c from mitochondria, cleavage of caspase 9, 3 and poly-adenosine diphosphate-ribose polymerase leading to apoptosis. One HCH analogue was also effective in vivo in SCID mice against grafts expressing the T315I mutation, although to a lesser extent than grafts expressing wild type Bcr-Abl, without showing significant bodyweight loss. Our data describe the role of JNK-dependent endothelial nitric oxide synthase-mediated nitric oxide for anti-CML activity of HCH and this molecule merits further testing in pre-clinical and clinical settings.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects*
  • Benzamides
  • Blotting, Western
  • Drug Resistance, Neoplasm / drug effects*
  • Eugenol / analogs & derivatives*
  • Eugenol / chemistry
  • Eugenol / pharmacology
  • Flow Cytometry
  • Fusion Proteins, bcr-abl / genetics
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / metabolism
  • MAP Kinase Kinase 4 / metabolism*
  • Male
  • Membrane Potential, Mitochondrial / drug effects
  • Mice
  • Mice, Nude
  • Mice, SCID
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type III / metabolism*
  • Phosphorylation / drug effects
  • Piper betle / chemistry*
  • Piperazines / pharmacology
  • Plant Extracts / pharmacology
  • Plant Leaves / chemistry
  • Pyrimidines / pharmacology
  • Reactive Oxygen Species / metabolism*
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Plant Extracts
  • Pyrimidines
  • Reactive Oxygen Species
  • 2-hydroxychavicol
  • Nitric Oxide
  • Eugenol
  • Imatinib Mesylate
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III
  • Fusion Proteins, bcr-abl
  • MAP Kinase Kinase 4